Acumen Pharmaceuticals, Inc.ABOS

$2.26+0.01 (+0.44%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$143M

Micro-cap

-80%

2021 — today

10-Year Price

-88%

2021 — today

52-Week Range

$1.11$3.37

Current $2.26· 51%

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.

Valuation in context

P/E ratio

-1.2

N/A

Not meaningful — company is unprofitable

P/B ratio

1.6

Historically pricey

Historically pricey — last 10 years

FCF Yield

-73.9%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when ABOS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.